Conditional marketing authorization granted in E.U. for Ondexxya to reverse factor Xa inhibitors April 29, 2019
AstraZeneca and Ionis Pharmaceuticals collaborate on antisense oligonucleotide targeting FOXP3 April 29, 2019
RSS